Inventor · disambiguated record
Orit Foord
Also filed as: FOORD ORIT
78 granted patents·16 pending applications·1,003 citations·filing 1999–2022
99Inventor score
Top patents by PatentIndex Score
94 records- 0198US11033634B2Light chain variable regionsABBVIE STEMCENTRX LLC·Filed 2019·Granted Jun 15, 2021·6 cites·16 claims
- 0297US9089615B2Anti-DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·21 cites·30 claims
- 0397US8986972B2Nucleic acid encoding DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Mar 24, 2015·22 cites·30 claims
- 0497US7736644B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Jun 15, 2010·77 cites·115 claims
- 0597US7628986B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Dec 8, 2009·119 cites·83 claims
- 0696US9937268B2Anti-DLL3 antibody drug conjugates and methods of useABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 10, 2018·9 cites·30 claims
- 0796US9931421B2Methods of delivering DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 3, 2018·9 cites·30 claims
- 0896US9931420B2Methods of making DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 3, 2018·9 cites·30 claims
- 0996US9878053B2Methods of delivering DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 30, 2018·9 cites·30 claims
- 1096US9867887B1Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 16, 2018·9 cites·30 claims
- 1196US9861708B2Kits containing DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 9, 2018·9 cites·30 claims
- 1296US9855343B2Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 2, 2018·9 cites·30 claims
- 1396US9775916B1Anti-DLL3 antibody drug conjugates for treating cancerABBVIE STEMCENTRX LLC·Filed 2017·Granted Oct 3, 2017·9 cites·30 claims
- 1496US9770518B1Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Sep 26, 2017·9 cites·30 claims
- 1596US9764042B1Methods of making DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Sep 19, 2017·9 cites·30 claims
- 1696US9358304B1Methods of making DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Jun 7, 2016·10 cites·30 claims
- 1796US9352051B1Kits containing DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted May 31, 2016·10 cites·30 claims
- 1896US9353182B2Anti-DLL3 antibodiesSTEMCENTRX INC·Filed 2015·Granted May 31, 2016·10 cites·21 claims
- 1996US9334318B1Multivalent DLL3 antibodiesSTEMCENTRX INC·Filed 2016·Granted May 10, 2016·11 cites·28 claims
- 2096US9155803B1Anti-DLL3 antibody drug conjugates and methods of useSTEMCENTRX INC·Filed 2015·Granted Oct 13, 2015·10 cites·30 claims
- 2196US9133271B1Anti-DLL3 antibody drug conjugates and methods of useSTEMCENTRX INC·Filed 2015·Granted Sep 15, 2015·10 cites·30 claims
- 2296US9089617B2Anti-DLL3 antibody drug conjugatesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·13 cites·30 claims
- 2396US7566772B2Antibodies against interleukin-1βAMGEN FREMONT INC·Filed 2006·Granted Jul 28, 2009·72 cites·19 claims
- 2496US7202343B2Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereofABGENIX INC·Filed 2003·Granted Apr 10, 2007·78 cites·39 claims
- 2595US10137204B2Anti-DLL3 antibody drug conjugates for treating cancerABBVIE STEMCENTRX LLC·Filed 2016·Granted Nov 27, 2018·8 cites·33 claims
- 2695US9486537B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 8, 2016·9 cites·22 claims
- 2795US9480757B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 1, 2016·9 cites·29 claims
- 2895US9107961B2Anti-DLL3 antibody drug conjugates for treating cancerSTEM CENTRX INC·Filed 2014·Granted Aug 18, 2015·11 cites·30 claims
- 2995US9089616B2Anti-DLL3 antibody drug conjugates and methods of useSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·10 cites·30 claims
- 3095US7285269B2Antibodies directed to tumor necrosis factorAMGEN FREMONT INC·Filed 2003·Granted Oct 23, 2007·101 cites·35 claims
- 3194US9090683B2Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·10 cites·30 claims
- 3294US7964193B2Antibodies against interleukin-1 βAMGEN FREMONT INC·Filed 2009·Granted Jun 21, 2011·29 cites·12 claims
- 3394US7585500B2Fully human monoclonal antibodies to IL-13AMGEN INC·Filed 2005·Granted Sep 8, 2009·36 cites·3 claims
- 3493US9409995B2PTK7 modulators and methods of useFOORD ORIT·Filed 2012·Granted Aug 9, 2016·39 cites·29 claims
- 3593US9096672B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Aug 4, 2015·16 cites·38 claims
- 3691US8604174B2High affinity fully human monoclonal antibodies to interleukin-8BABCOOK JOHN·Filed 2006·Granted Dec 10, 2013·30 cites·7 claims
- 3790US9534058B2Anti-CD324 monoclonal antibodies and uses thereofSTEM CENTRX INC·Filed 2013·Granted Jan 3, 2017·10 cites·10 claims
- 3890US9345784B1Methods of delivering DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted May 24, 2016·3 cites·30 claims
- 3990US8362215B2Antibodies immunoreactive with heregulin-coupled HER3TRELLIS BIOSCIENCE LLC·Filed 2010·Granted Jan 29, 2013·9 cites·23 claims
- 4090US7736648B2Anti-RSV G protein antibodiesTRELLIS BIOSCIENCE INC·Filed 2008·Granted Jun 15, 2010·13 cites·21 claims
- 4189US10836831B2Anti-PTK7 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2018·Granted Nov 17, 2020·3 cites·23 claims
- 4289US9676850B2Anti SEZ6 antibodies and methods of useSTEM CENTRX INC·Filed 2013·Granted Jun 13, 2017·10 cites·12 claims
- 4389US9173959B1Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2015·Granted Nov 3, 2015·3 cites·30 claims
- 4488US11135245B2Engineered γδ T-cellsADICET BIO INC·Filed 2015·Granted Oct 5, 2021·5 cites·12 claims
- 4588US9481727B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 1, 2016·2 cites·26 claims
- 4688US9062113B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jun 23, 2015·7 cites·28 claims
- 4787US7482434B2Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereofASTRAZENECA AB·Filed 2006·Granted Jan 27, 2009·8 cites·24 claims
- 4886US7994302B2Fully human monoclonal antibodies to IL-13AMGEN INC·Filed 2009·Granted Aug 9, 2011·8 cites·8 claims
- 4983US9320812B2Modulators and methods of useHAMPL JOHANNES·Filed 2011·Granted Apr 26, 2016·8 cites·36 claims
- 5082US9914784B2PTK7 modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2016·Granted Mar 13, 2018·3 cites·19 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Orit Foord files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →